Life Science Washington Institute Recognizes ProfoundBio Co-Founders with 2024 Entrepreneurial Achievement Award

Life Science Washington Institute (LSWI) has awarded the 2024 Entrepreneurial Achievement Award to Dr. Baiteng Zhao, Ph.D., and Dr. Tae H. Han, Ph.D., the co-founders of ProfoundBio. This award recognizes their significant entrepreneurial accomplishments and contributions to Washington state’s economic development, highlighted by Genmab’s $1.8 billion acquisition of ProfoundBio, one of the top life science deals in 2024.
“ProfoundBio is a powerful example of how Washington’s life sciences ecosystem continues to thrive as talented leaders remain in the region, build new companies, and drive innovation,” said Richard Giersch, Executive Director of LSWI. “The company was able to develop such strong investor interest and ultimately be acquired because of its innovative proprietary technology platforms and a robust pipeline of drug candidates.”
As proud graduates of LSWI’s Washington Innovation Network (WIN) mentoring program, Dr. Han and Dr. Zhao represent the exceptional homegrown talent driving innovation in Washington state’s vibrant life science hub.